Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
Price Target
Average
33.79%
Revenue Forecast
Estimate
63.61%
EBIT
Estimate
--41.04%
Net Income
Estimate
32.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Protagonist Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for PTGX of $52.5 , with forecasts ranging from
a
low of
$38 to a high of $62 .
PTGX Lowest Price Target
Wall Street Target
38 USD
-3.16%
PTGX Average Price Target
Wall Street Target
52.5 USD
33.79%
PTGX Highest Price Target
Wall Street Target
62 USD
58.00%
REVENUE FORECAST
Revenue Forecast Chart PTGX
EBIT FORECAST
EBIT Forecast Chart PTGX
NET INCOME FORECAST
Net Income Chart PTGX